lilly tirzepatide approval 'Miracle' drugs could remake the weight loss industry US FDA says Lilly's weight-loss

A growing body of mechanistic research shows that GLP-1 agonists reduce pro-inflammatory markers including TNF-alpha, IL-6, and CRPall elevated in fibromyalgia patients

Per publicly available announcements, the FDA issued more than 50 warning letters to GLP-1 compounders and manufacturers in September 2025, followed by an additional 30 warning letters to telehealth firms in early 2026, targeting false or misleading marketing claims about compounded semaglutide and tirzepatide products

There are four different bariatric surgery procedures: Gastric Bypass Surgery (laparoscopic Roux-en-Y) This procedure reduces the stomach through stapling and bypasses a portion of the small intestine, resulting in less calorie absorption

Contrarily to the other methods listed before, vaccine-based approaches do not only aim to target senescent cells in tissues, but also senescent immune cells, which can be responsible for age-related diseases 60